HIPRA, a biotechnological company and member of Catalonia.health, and Elanco Animal Health have announced a strategic partnership to bring two vaccines against avian metapneumovirus (aMPV) to the United States poultry market.

The Catalan company Rob Surgical, specialising in robotic technology for minimally invasive surgery and a member of Catalonia.health, has inaugurated its first manufacturing plant in El Prat de Llobregat (Barcelona). 

The biotechnology company Inbiomotion,a member of Catalonia.health, has announced that its MAF Test® has been included in the SEOM-GEICAM-SOLTI 2025 Clinical Practice Guidelines for early-stage breast cancer, a key consensus document for clinical decision-making in Spain and an international reference.

CMG MedDev, a consulting company specialising in regulatory affairs, quality management and clinical consulting for medical devices, in vitro diagnostics and solutions based on software and artificial intelligence, and a member of Catalonia.health, has been awarded the 2025 Cum Laude Award for Innovation in Regulatory Consulting for Medical Devices. 

Barcelona, November 2025 – Catalonia.health hosted this November a working visit by the European consortium RISEMED4EU (Regional Innovation for Smart Ecosystems in Health and Medicine in the EU), an initiative bringing together eight regions from eight European countries with the aim of boosting innovation in health and personalised medicine through interregional collaboration and advanced technology

The technology centre Eurecat, a member of Catalonia.health, and the Catalan Institute of Oncology (ICO) have launched a pilot test of a digital platform based on artificial intelligence aimed at promoting healthy habits and emotional management in order to contribute to primary cancer prevention.  

The biopharmaceutical company Oniria Therapeutics, a member of Catalonia.health, is collaborating with the Vall d’Hebron Institute of Oncology (VHIO) and the Institute of Chemical Research of Catalonia (ICIQ) on the development of the innovative drug ONR-001, aimed at the treatment of treatment-resistant colorectal cancer.

The biopharmaceutical company Oryzon Genomics, a member of Catalonia.health, has presented new clinical data on iadademstat in patients with acute myeloid leukaemia (AML) at the 67thAnnual Meeting of the American Society of Hematology (ASH).

Integra Therapeutics, empresa biotecnològica especialitzada en tecnologia de redacció genètica d’última generació, membre de Catalonia.health, ha anunciat el nomenament de Miles Gerson com a president independent del seu Consell d’Administració.

The biopharmaceutical company Reig Jofre, a member of Catalonia.health, has announced the consolidation of its stake in Leanbio, a biotechnology company specialising in the development and production of biotechnological active pharmaceutical ingredients and also a member of Catalonia.health. 

The biotechnology start-up Nuage Therapeutics, a member of Catalonia.health, has secured €2.7 million in funding from the Spanish State Research Agency (AEI) of the Ministry of Science, Innovation and Universities

The Josep Carreras Leukaemia Research Institute, a member of Catalonia.health, is leading a new international alliance to accelerate the development of innovative diagnostic tools and therapeutic strategies for follicular lymphoma, one of the most common blood cancers.

mjn-neuro, a start-up specialising in neurotechnology applied to digital health and a member of Catalonia.health, and the European pharmaceutical group Neuraxpharm have announced plans to launch EPISERAS®

GoodGut, a biotechnology company specialising indigestive health solutions based on the intestinal microbiota and a member of Catalonia.health, is participating in a study being carried out at four primary care centres in the Girona Health Region to improve the diagnosis of irritable bowel syndrome.

The biotechnology company HIPRA, a member of Catalonia.health, is part of a European consortium led by the Medical University of Vienna aimed at developing a next-generation intranasal influenza vaccine. 

Catalonia.health welcomed a visit this December from an institutional and business delegation from Malaysia's health sector, interested in gaining first-hand knowledge of the Catalan medtech ecosystem and the know-how of the country's health innovation companies and institutions.

Arantxa Sanz, CEO of Catalonia.health, participated in the European Health Summit in Brussels addressing how AI influences the interpretation of European health regulations. The study presented by LLYC reveals significant disparities in quality and access to information based on user profile and geography, emphasizing the need for reliable sources.

Catalonia.health has opened the call for its annual awards. The Catalan health ecosystem once again recognises the excellence of its members through awards that highlight innovation, collaboration and impact on health.

Catalonia.Health welcomes Marta Herrera as Head of Communications for the organisation. With this addition, we are strengthening our commitment to strategic communication in order to amplify the visibility and projection of the association's leadership, equipping ourselves with the capabilities to empower our community and ensure the impact of the valuable actions we generate together.

The technology centre Eurecat, a member of Catalonia.health, has received the IX National Congress of Entrepreneurial Scientists award for the development of a 3D-printed vascular stent.